The cardiovascular effects of adrenaline, dobutamine and milrinone in rabbits using pressure-volume loops and guinea pig isolated atrial tissue

Anaesthesia and Intensive Care

Volumn 35, Issue 2, 2007, Pages 180-188

  Royse, C F ^a   Royse, A G ^a   Rohrlach, R ^a   Wright, C E ^a   Angus, J A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adrenaline; Dobutamine; Milrinone

Indexed keywords

ADRENALIN; DOBUTAMINE; MILRINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART RATE; INOTROPISM; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSURE VOLUME CURVE; RABBIT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 34247469391     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0703500207     Document Type: Article

References (21)

1. Binah O, Sodowick B, Vulliemoz Y, Danilo P, Jr., Rosen M. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation 1986; 73(3 Pt 2): III46-51.
2. Kocic I. Modulation of the contractility of guinea pig papillary muscle by the activation of ATP-sensitive K+ channels. Eur J Pharmacol 1996; 301:115-119.
3. Muller B, Lugnier C, Stoclet JC. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. J Cardiovasc Pharmacol 1990; 15:444-451.
4. Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C et al. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109:1302-1312.
5. Eichhorn EJ, Konstam MA, Weiland DS, Roberts DJ, Martin TT, Stransky NB et al. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60:1329-1333.
6. Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984; 70:1030-1037.
7. Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW. Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 2000; 28:249-252.
8. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Eng] J Med 1991; 325:1468-1475.
9. Cuffe MS, Califf RM, Adams KF, Jr., Benza R, Bourge R, Colucci WS et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002; 287:1541-1547.
10. Kass DA. Clinical evaluation of left heart function by conductance catheter technique. Eur Heart J 1992; 13(Suppl E):57-64.
11. Greenberg NL, Firstenberg MS, Castro PL, Main M, Travaglini A, Odabashian JA et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002; 105:99-105.
12. Ritchie RH, Hii JT, Horowitz JD. Relationship between myocardial milrinone content and its acute hemodynamic and electrophysiologic effects. J Cardiovasc Pharmacol 1998; 31:885-893.
13. Steendijk P, Baan J. Comparison of intravenous and pulmonary artery injections of hypertonic saline for the assessment of conductance catheter parallel conductance. Cardiovasc Res 2000; 46:82-89.
14. Steendijk P, Staal E, Jukema JW, Baan J. Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 2001; 281:H755-763.
15. De Hert SG, Gillebert TC, Ten Broecke PW, Mertens E, Rodrigus IE, Moulijn AC. Contraction-relaxation coupling and impaired left ventricular performance in coronary surgery patients. Anesthesiology 1999; 90:748-757.
16. Kishi T, Nakahashi K, Ito H, Taniguchi S, Takaki M. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ. Clin Exp Pharmacol Physiol 2001; 28:737-742.
17. Baan J, Van der Velde ET. Sensitivity of left ventricular end-systolic pressure-volume relation to type of loading intervention in dogs. Circ Res 1988; 62:1247-1258.
18. Lobato EB, Urdaneta F, Martin TD, Gravenstein N. Effects of milrinone versus epinephrine on grafted internal mammary artery flow after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14:9-11.
19. Taniguchi T, Shibata K, Saito S, Matsumoto H, Okeie K. Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration. Intensive Care Med 2000; 26:1089-1093.
20. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320:677-683.
21. Thackray S, Witte K, Clark AL, Cleland JG. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT. Eur J Heart Fail 2000; 2:209-212.